An outbreak of pneumococcal meningitis among older children (≥5 years) and adults after the implementation of an infant vaccination programme with the 13-valent pneumococcal conjugate vaccine in Ghana

Abstract

BackgroundAn outbreak of pneumococcal meningitis among non-infant children and adults occurred in the Brong-Ahafo region of Ghana between December 2015 and April 2016 despite the recent nationwide implementation of a vaccination programme for infants with the 13-valent pneumococcal conjugate vaccine (PCV13).MethodsCerebrospinal fluid (CSF) specimens were collected from patients with suspected meningitis in the Brong-Ahafo region. CSF specimens were subjected to Gram staining, culture and rapid antigen testing. Quantitative PCR was performed to identify pneumococcus, meningococcus and Haemophilus influenzae. Latex agglutination and molecular serotyping were performed on samples. Antibiogram and whole genome sequencing were performed on pneumococcal isolates.ResultsEight hundred eighty six patients were reported with suspected meningitis in the Brong-Ahafo region during the period of the outbreak. In the epicenter district, the prevalence was as high as 363 suspected cases per 100,000 people. Over 95 % of suspected cases occurred in non-infant children and adults, with a median age of 20 years. Bacterial meningitis was confirmed in just under a quarter of CSF specimens tested. Pneumococcus, meningococcus and Group B Streptococcus accounted for 77 %, 22 % and 1 % of confirmed cases respectively. The vast majority of serotyped pneumococci (80 %) belonged to serotype 1. Most of the pneumococcal isolates tested were susceptible to a broad range of antibiotics, with the exception of two pneumococcal serotype 1 strains that were resistant to both penicillin and trimethoprim-sulfamethoxazole. All sequenced pneumococcal serotype 1 strains belong to Sequence Type (ST) 303 in the hypervirulent ST217 clonal complex.ConclusionThe occurrence of a pneumococcal serotype 1 meningitis outbreak three years after the introduction of PCV13 is alarming and calls for strengthening of meningitis surveillance and a re-evaluation of the current vaccination programme in high risk countries.Electronic supplementary materialThe online version of this article (doi:10.1186/s12879-016-1914-3) contains supplementary material, which is available to authorized users.

Burden of Pneumococcal Disease in Northern Togo before the Introduction of Pneumococcal Conjugate Vaccine

“…The incidence of serotype 1 Sp fluctuated over time, with a decline in Sp1 coinciding with an increase in other pathogens. Similar waves of serotype 1 meningitis have been described in Ghana [14,37]. As observed previously, over one-third of Sp meningitis cases died in hospital despite receiving appropriate treatment with ceftriaxone; this highlights the importance of disease prevention to reduce morbidity and mortality.…”

Susceptibility of Streptococcus pneumoniae causing bacterial meningitis in children in Yaoundé (Cameroon): results of a surveillance site

“…Serotype 12F in particular is emerging as an important cause of invasive pneumococcal disease with the propensity to cause outbreaks. 10 The global resistance profile showed resistance to penicillin G, erythromycin, tetracyclin and trimethoprim-sulfamethoxazole, with PNSSP at 42.85%. These are the antibiotics commonly used in auto-medication as they can be obtained without prescription at non-conventional pharmacies.…”

“…9 Kwambana found that Pneumococci expressing the serotype 1 capsule dominated the West African pneumococcal meningitis outbreaks. 10 Some studies reported that strains isolated from the upper respiratory tract of subjects in the Center Region of Cameroon were relatively sensitive to β-lactamines. 11 The increasing resistance of S. pneumoniae to penicillin and other beta-lactamines raises enormous challenges in treatment regimens.…”

State-of-the-art in the pneumococcal field: Proceedings of the 11th International Symposium on Pneumococci and Pneumococcal Diseases (ISPPD-11)

“…Optimal population-specific vaccination strategies targeting outbreak control are needed. Additionally, preparation for future outbreaks in Africa as well as the Asia-Pacific region requires strengthened surveillance [50].…”